Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- RSNA: Appendicitis? There's an App for That
- Women's Institutes Are Asking Their Pharmacist, UK
- Study Finds ICDs Extend The Lives Of Heart Attack Survivors By An Entire Year
- Multidisciplinary Cancer Congress
- NPA Responds To Study On Care Homes' Use Of Medicines
- Ablynx Wins Award For 'Most Successful Early Phase Trial'
- Seattle Genetics Initiates Phase I Clinical Trial Of Antibody-Drug Conjugate SGN-75
- S.C. Medical Home Pilot For Diabetes Enrolls 1,110
- Forest Laboratories, Inc. And Gedeon Richter Announce Positive Results From A Phase IIb Study Of Cariprazine For The Treatment Of Schizophrenia
- Drug Option For Patients Beginning HIV Treatment Studied
Potentially Dangerous Drug Interactions Missed By Prescribers
Posted by: admin in Pharmacy Drugs on August 29th, 2009
Research led by The University of Arizona College of Pharmacy has found that medication prescribers correctly identified fewer than half of drug pairs with potentially dangerous drug-drug interactions.
These findings raise concern because of the high number of drugs Americans take: an average of 2.3 medications is prescribed during each physician office visit.
A synopsis of the research was published in May Research Activities, a digest of research findings intended to contribute to the national policymaking process.
The researchers, led by Daniel Malone, PhD, professor at the UA College of Pharmacy, mailed a questionnaire to 12,500 U.S. prescribers who were selected based on a history of prescribing drugs associated with known potential for drug-drug interaction. Prescribers were primarily physicians, physicians’ assistants and nurse practitioners.
Recipients were asked to classify 14 drug pairs as “contraindicated,” “may be used together but with monitoring” or “no interaction.” Respondents could also state that they were “not sure.”
For the drug pairs, one commonly prescribed medication was matched with another commonly prescribed medication.
The 950 respondents classified 42.7 percent of all drug combinations correctly.
Of the 14 drug pairs presented, four of them were contraindicated, meaning they should not be used together. A majority of prescribers correctly identified only one of the four pairs as contraindicated.
Moreover, for half of the 14 drug pairs, more than one-third of the respondents answered that they were “not sure,” and two of these drug pairs were contraindicated.
“The study found a very low rate of recognition of these particular interactions,” says Malone, “and some of these interactions are very common.”
Use of several of the contraindicated drug pairs could be dangerous. For example, taking sildenafil (Viagra®) and nitrates, such as isosorbide mononitrate, can be life-threatening.
According to Malone, the research indicates that health professional programs are not doing enough to teach students about potential drug-drug interactions. Consequently, patients should be sure to tell their pharmacist of all the medications they are taking.
Source:
Karin Lorentzen
University of Arizona, College of Pharmacy
View drug information on Viagra.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.





